Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 9/20 | 0.93 |
| ▸ | MEN1 | O00255 | 1/20 | 0.87 |
| ▸ | TP53 | P04637 | 1/20 | 0.87 |
| ▸ | MAPT | P10636 | 1/20 | 0.87 |
| ▸ | MTOR | P42345 | 1/20 | 0.87 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.87 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29669968 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6HPGDALDH1A1 | |
| SCHEMBL29368417 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6HPGDALDH1A1 | |
| SCHEMBL5088067 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6HPGDALDH1A1 | |
| SCHEMBL1155582 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6HPGDALDH1A1 | |
| Nonivamide SCHEMBL81939 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6HPGDALDH1A1 | |
| SCHEMBL8373082 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6HPGDALDH1A1 | |
| SCHEMBL1155739 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6HPGDALDH1A1 | |
| SCHEMBL679954 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6HPGDALDH1A1 | |
| SCHEMBL2400979 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6HPGDALDH1A1 | |
| SCHEMBL5889449 | 1.00 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4210687-B1 | TRPV1 AGONISTS IN THE PREVENTION OF DIABETIC ULCERS | IMPERIAL COLLEGE INNOVATIONS LTD (GB) | 2026-05-27 | — | — | EP | claimed |
| EP-3911172-B1 | COMBINATION OF SATIETY COMPONENTS WITH ARGININE | SYMRISE AG (DE) | 2026-04-15 | — | — | EP | claimed |
| EP-3595697-B1 | CLEAVABLE ESTERS FOR NANOCARRIER-BASED CANCER THERAPY | CHILDRENS HOSPITAL PHILADELPHIA (US) | 2025-02-12 | — | — | EP | claimed |
| EP-4486857-A1 | FRAGRANCE COMPOSITIONS FOR SLEEP IMPROVEMENT | International Flavors & Fragrances Inc. (US) | 2025-01-08 | — | — | EP | claimed |
| EP-3969163-B1 | BIODEGRADABLE POLYUREA/POLYURETHANE MICROCAPSULES | SYMRISE AG (DE) | 2024-12-11 | — | — | EP | claimed |
| EP-4452941-A1 | ACTIVE INGREDIENTS WITH SIALAGOGUE AND TINGLING/FIZZY EFFECT, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2024-10-30 | — | — | EP | claimed |
| WO-2023168069-A1 | FRAGRANCE COMPOSITIONS FOR SLEEP IMPROVEMENT | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2023-09-07 | — | — | WO | claimed |
| EP-3142779-B1 | FOAM PRODUCTION EQUIPMENT AND METHOD | POULNAIS ERIC (FR) | 2023-04-26 | — | — | EP | claimed |
| EP-4033887-A1 | METHOD FOR CONTROLLED ELICITATION OF PEPPER PLANTS UNDER CULTIVATION TO INCREASE THEIR SYNTHESIS OF SECONDARY METABOLITES OF INDUSTRIAL INTEREST | ID4Feed (FR) | 2022-08-03 | — | — | EP | claimed |
| EP-3131531-B1 | TOPICAL COMPOSITIONS FOR PAIN RELIEF, MANUFACTURE AND USE | PROPELLA THERAPEUTICS INC (US) | 2022-04-06 | — | — | EP | claimed |
| EP-3388057-B1 | A PAIN RELIEF COMPOSITION, COMPRISING A TRPV1 SELECTIVE AGONIST, AND MANUFACTURE AND USES THEREOF | PROPELLA THERAPEUTICS INC (US) | 2022-03-09 | — | — | EP | claimed |
| EP-3744322-B1 | PATCH | HISAMITSU PHARMACEUTICAL CO (JP) | 2022-03-09 | — | — | EP | claimed |
| EP-4223352-B1 | DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS | UROTRONIC INC (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-12605342-B2 | Polymer-encapsulated drug particles | TONIC MEDICAL, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| EP-3969163-A1 | BIODEGRADABLE POLYUREA/POLYURETHANE MICROCAPSULES | Symrise AG (DE) | 2022-03-23 | — | — | EP | disclosed |
| EP-3969164-A1 | METHOD FOR PRODUCING MICROCAPSULES | Symrise AG (DE) | 2022-03-23 | — | — | EP | disclosed |
| EP-3969162-A1 | POLYUREA/POLYURETHANE MICROCAPSULES | Symrise AG (DE) | 2022-03-23 | — | — | EP | disclosed |
| EP-3969165-A1 | BIODEGRADABLE POLYUREA/POLYURETHANE MICROCAPSULES | Symrise AG (DE) | 2022-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605342-B2 | Polymer-encapsulated drug particles | MUC1, SLC10A2, EGFR | CYP1A2 1652/4885CYP3A4 1392/4885CYP2D6 1296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.